About this trial
This research focuses on behavioral sensitization (BS) a specific behavioural disturbance in crack-cocaine addiction. The primary objective is to observe whether BS can be demonstrated in an ecological setting in crack dependent users by continuous actimetry for 3 weeks.
It is planned to include 20 persons with a current crack-cocaine addiction with a preferential use of rapid administration route (intravenous or smoke), in a care institution: Fernand Widal Hospital.
In the proposed research, the investigators will assess the movements of crack-cocaine dependent users in relation to consumption. They will have to wear continuously for 3 weeks an actimeter. They will also have 3 blood tests trying to identify biomarkers of BS.
Eligibility criteria
Qualifiers
> 18 years
Have a current crack-cocaine use disorder defined as Severe Intensity Use Disorder (6 or more DSM5 criteria), AND preferential use of rapid administration route (intravenous or smoked)
Self-identified male or female (n=10 males, n=10 females)
Negative pregnancy test for females and use of effective contraception
Disqualifiers
• Patient with a psychiatric disorder or symptoms that are not currently stabilized
Patient who is a minor or under protective supervision (curatorship or guardianship)
Patient in care at the request of a judicial authority (therapeutic injunction, classification with orientation)
Pregnant or breastfeeding women
Trial design
Treatments tested in this trial
- Observation of behavior and search of biomarkers with 3 blood tests.3 weeks wearing an actimeter
- 3 blood tests
Treatment groups
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator